AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35395497 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical exercise break (PE group)
Number of subjects: 60
Study 35395497 — intervention group
Group type: COMPARATOR
Intervention: Prolonged sitting (PS group)
Number of subjects: 60
Study 34127492 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural Language Processing (NLP) on free-text clinical notes and reports
Number of subjects: 800
Study 34127492 — intervention group
Group type: COMPARATOR
Intervention: Manual medical record review by trained ARIC abstractors (reference standard)
Number of subjects: 800
Study 32996583 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-assisted cognitive rehabilitation with a neuropsychologist (Group A)
Number of subjects: 167
Study 32996583 — intervention group
Group type: COMPARATOR
Intervention: Home cognitive self-exercises (Group B)
Number of subjects: 167
Study 32996583 — intervention group
Group type: COMPARATOR
Intervention: Phone follow-up (Group C)
Number of subjects: 167
Study 36254728 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-Eluting Stent (DES)
Number of subjects: 775
Study 36254728 — intervention group
Group type: COMPARATOR
Intervention: Bare Metal Stent (BMS)
Number of subjects: 775
Study 34169339 — intervention group
Group type: EXPERIMENTAL
Intervention: ECOG PS > 1
Number of subjects: 106
Study 34169339 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI > 25 kg/m2
Number of subjects: 106
Study 34169339 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative norepinephrine > 0.11 µg/kg/min
Number of subjects: 106
Study 34169339 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative fresh frozen plasma (FFP) > 17 units
Number of subjects: 106
Study 33721982 — intervention group
Group type: EXPERIMENTAL
Intervention: High-volume resistance exercise session
Number of subjects: 20
Study 33721982 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-volume resistance exercise session
Number of subjects: 20
Study 33721982 — intervention group
Group type: COMPARATOR
Intervention: Control session (no exercise)
Number of subjects: 20
Study 33827126 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil infusion rate of 0.1 μg/kg/min
Number of subjects: 63
Study 33827126 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil infusion rate of 0.2 μg/kg/min
Number of subjects: 63
Study 33827126 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil infusion rate of 0.4 μg/kg/min
Number of subjects: 63
Study 33827126 — intervention group
Group type: EXPERIMENTAL
Intervention: Local anesthesia with 2% lidocaine containing 12.5 μg/mL epinephrine
Number of subjects: 63
Study 33827126 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (0.1, 0.2, 0.4 μg/kg/min)
Number of subjects: 63
Study 35596187 — intervention group
Group type: EXPERIMENTAL
Intervention: Severely malnourished children (cases)
Number of subjects: 201
Study 34313843 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral acetaminophen 1 g
Number of subjects: 60
Study 34313843 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 32265500 — intervention group
Group type: EXPERIMENTAL
Intervention: Dasatinib (100 mg)
Number of subjects: 260
Study 32265500 — intervention group
Group type: COMPARATOR
Intervention: Imatinib (≥400 mg)
Number of subjects: 260
Study 35101100 — intervention group
Group type: EXPERIMENTAL
Intervention: SBIRT (Screening, Brief Intervention, and Referral to Treatment)
Number of subjects: 600
Study 35101100 — intervention group
Group type: COMPARATOR
Intervention: Referral as usual (usual care)
Number of subjects: 600
Study 33626921 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight management program adapted for children with autism; duration: 8 weeks; participation with a parent or adult caregiver.
Number of subjects: 15
Study 33626921 — intervention group
Group type: COMPARATOR
Intervention: Weight management program for children without autism; duration: 8 weeks; participation with a parent or adult caregiver.
Number of subjects: 15
Study 32717956 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive trunk resistance and stretching exercise program (60-90 min sessions, 3 days per week for 12 weeks)
Number of subjects: 17
Study 32717956 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified what the control intervention was)
Number of subjects: 17
Study 33692621 — intervention group
Group type: EXPERIMENTAL
Intervention: BreatheMate device with electronic reminders for budesonide/formoterol 160/4.5 μg twice daily
Number of subjects: 138
Study 33692621 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving the same medication without electronic reminders
Number of subjects: 138
Study 34855657 — intervention group
Group type: EXPERIMENTAL
Intervention: Diterpene ginkgolides meglumine injection (DGMI) 25 mg/d for 14 days
Number of subjects: 80
Study 32291565 — intervention group
Group type: EXPERIMENTAL
Intervention: Dating Matters® Comprehensive Teen Dating Violence Prevention Model
Number of subjects: 0
Study 32291565 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 36262727 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 μg nitroglycerine (Group N4)
Number of subjects: 70
Study 36262727 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 μg nitroglycerine (Group N8)
Number of subjects: 70
Study 32522503 — intervention group
Group type: EXPERIMENTAL
Intervention: Bitter-flavoured, 7.5mm film-coated tablets
Number of subjects: 153
Study 36093873 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-COVID-19 recruitment
Number of subjects: 485
Study 36093873 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-COVID-19 recruitment
Number of subjects: 485
Study 36093873 — intervention group
Group type: COMPARATOR
Intervention: Pre-COVID-19 eligibility screening
Number of subjects: 485
Study 36093873 — intervention group
Group type: COMPARATOR
Intervention: Demographic comparison
Number of subjects: 485
Study 33168558 — intervention group
Group type: EXPERIMENTAL
Intervention: In-depth education on risk-reducing behaviours
Number of subjects: 120
Study 33168558 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 120
Study 35188874 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vitamin D supplementation for 8 weeks along with conventional dry eye treatment (artificial tears)
Number of subjects: 100
Study 35188874 — intervention group
Group type: COMPARATOR
Intervention: Conventional dry eye treatment (artificial tears) without vitamin D supplementation
Number of subjects: 100
Study 33236287 — intervention group
Group type: EXPERIMENTAL
Intervention: INTP5 (pegfilgrastim biosimilar)
Number of subjects: 200
Study 33236287 — intervention group
Group type: COMPARATOR
Intervention: pegfilgrastim-ref
Number of subjects: 200
Study 35546255 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal hepatitis B vaccine with topical imiquimod pre‐treatment (ID-Imq)
Number of subjects: 104
Study 35546255 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular hepatitis B vaccine with aqueous cream pre‐treatment (IM-Aq)
Number of subjects: 104
Study 32246138 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of cefotaxime (250 mg/kg/day) with oral acetaminophen (first dose 30 mg/kg, then 20 mg/kg every 6 hours)
Number of subjects: 375
Study 32246138 — intervention group
Group type: COMPARATOR
Intervention: Cefotaxime conventionally as boluses (62.5 mg/kg, 4 times per day) with placebo orally
Number of subjects: 375
Study 32246138 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of cefotaxime with oral acetaminophen
Number of subjects: 375
Study 32246138 — intervention group
Group type: COMPARATOR
Intervention: Cefotaxime conventionally as boluses with placebo orally
Number of subjects: 375
Study 35077452 — intervention group
Group type: EXPERIMENTAL
Intervention: Package of vector control interventions including larvivorous guppy fish, mosquito trapping with gravid-ovitraps, solid waste management, breeding-container coverage through community education and engagement.
Number of subjects: 0
Study 35077452 — intervention group
Group type: COMPARATOR
Intervention: Control Arm
Number of subjects: 0
Study 33105394 — intervention group
Group type: EXPERIMENTAL
Intervention: DriSti intervention (2 sessions with videos and interactive exercises on a computer tablet and one interactive face-to-face group session)
Number of subjects: 1492
Study 33105394 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 1492
Study 36250951 — intervention group
Group type: EXPERIMENTAL
Intervention: Obstructive sleep apnea (OSA) patients
Number of subjects: 26
Study 36250951 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 26
Study 34747186 — intervention group
Group type: EXPERIMENTAL
Intervention: Amulet
Number of subjects: 221
Study 34747186 — intervention group
Group type: COMPARATOR
Intervention: Watchman
Number of subjects: 221
Study 33989320 — intervention group
Group type: EXPERIMENTAL
Intervention: Writing exercise focusing on body functionality of 'Anne'
Number of subjects: 98
Study 33989320 — intervention group
Group type: COMPARATOR
Intervention: Active control group (describing 'Anne's' home)
Number of subjects: 98
Study 33106168 — intervention group
Group type: COMPARATOR
Intervention: Placebo (288 mg of rice protein, 109.3 mg microcrystalline cellulose)
Number of subjects: 0
Study 34004154 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of the HOME-CoV rule during the interventional period
Number of subjects: 3000
Study 34004154 — intervention group
Group type: COMPARATOR
Intervention: Observational period without the HOME-CoV rule
Number of subjects: 3000
Study 34004154 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients treated at home during the interventional period
Number of subjects: 3000
Study 34004154 — intervention group
Group type: COMPARATOR
Intervention: Patients treated at home during the observational period
Number of subjects: 3000
Study 35246395 — intervention group
Group type: EXPERIMENTAL
Intervention: Tianjiang Xueshuantong Wan pills
Number of subjects: 72
Study 35246395 — intervention group
Group type: COMPARATOR
Intervention: rt‐PA intravenous thrombolysis
Number of subjects: 72
Study 33483908 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety skills training
Number of subjects: 229
Study 33483908 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety inoculation training
Number of subjects: 229
Study 33483908 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive atmosphere for safety learning
Number of subjects: 229
Study 33483908 — intervention group
Group type: EXPERIMENTAL
Intervention: Active learning techniques
Number of subjects: 229
Study 33483908 — intervention group
Group type: EXPERIMENTAL
Intervention: Core components overall
Number of subjects: 229
Study 32482392 — intervention group
Group type: EXPERIMENTAL
Intervention: Umbilical cord milking
Number of subjects: 56
Study 32482392 — intervention group
Group type: COMPARATOR
Intervention: Delayed cord clamping (DCC)
Number of subjects: 56
Study 616861719 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg immunologically active gluten/d
Number of subjects: 715
Study 616861719 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 715
Study 616861719 — intervention group
Group type: EXPERIMENTAL
Intervention: Gluten consumption pattern
Number of subjects: 715
Study 616861719 — intervention group
Group type: EXPERIMENTAL
Intervention: HLA risk group and gluten consumption pattern
Number of subjects: 715
Study 36870589 — intervention group
Group type: EXPERIMENTAL
Intervention: WFG-LASIK
Number of subjects: 100
Study 36870589 — intervention group
Group type: COMPARATOR
Intervention: WFO-LASIK
Number of subjects: 100
Study 36870589 — intervention group
Group type: EXPERIMENTAL
Intervention: WFG-LASIK or WFO-LASIK
Number of subjects: 100
Study 36870589 — intervention group
Group type: EXPERIMENTAL
Intervention: Preferred eye
Number of subjects: 100
Study 33262048 — intervention group
Group type: EXPERIMENTAL
Intervention: SuperPath approach
Number of subjects: 96
Study 33262048 — intervention group
Group type: COMPARATOR
Intervention: Conventional posterolateral approach
Number of subjects: 96
Study 35463674 — intervention group
Group type: EXPERIMENTAL
Intervention: All-inclusive and hierarchical rehabilitation nursing model combined with acupuncture
Number of subjects: 80
Study 35463674 — intervention group
Group type: COMPARATOR
Intervention: Routine rehabilitation nursing
Number of subjects: 80
Study 34158569 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label placebo (OLP) treatment
Number of subjects: 160
Study 34158569 — intervention group
Group type: COMPARATOR
Intervention: No placebo (control group)
Number of subjects: 160
Study 34927683 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus nasogastric feeding
Number of subjects: 189
Study 34927683 — intervention group
Group type: COMPARATOR
Intervention: Continuous nasogastric feeding
Number of subjects: 189
Study 33151321 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-day simulation-based cataract surgical training course
Number of subjects: 50
Study 33151321 — intervention group
Group type: COMPARATOR
Intervention: Standard surgical training only (Control)
Number of subjects: 50
Study 32191586 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (400 units per day)
Number of subjects: 91
Study 32191586 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (1000 mg per day)
Number of subjects: 91
Study 32191586 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E + C for 90 days
Number of subjects: 91
Study 32191586 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 91
Study 35105495 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccine
Number of subjects: 185
Study 35105495 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG + HBV group
Number of subjects: 185
Study 35105495 — intervention group
Group type: COMPARATOR
Intervention: HBV vaccine
Number of subjects: 185
Study 33771603 — intervention group
Group type: EXPERIMENTAL
Intervention: High-density SNP microarrays
Number of subjects: 180
Study 35123322 — intervention group
Group type: EXPERIMENTAL
Intervention: 4G-beta-D-Galactosylsucrose (LS)
Number of subjects: 20
Study 35123322 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 34337003 — intervention group
Group type: COMPARATOR
Intervention: Negative control (G2)
Number of subjects: 84
Study 34337003 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 laser irradiation (G3)
Number of subjects: 84
Study 34337003 — intervention group
Group type: EXPERIMENTAL
Intervention: CPP‐ACFP paste (G4)
Number of subjects: 84
Study 34337003 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 laser irradiation followed by CPP‐ACFP paste application (G5)
Number of subjects: 84
Study 34337003 — intervention group
Group type: EXPERIMENTAL
Intervention: CPP‐ACFP paste application followed by CO2 laser irradiation (G6)
Number of subjects: 84
Study 34337003 — intervention group
Group type: COMPARATOR
Intervention: Positive control (G1)
Number of subjects: 84
Study 34239050 — intervention group
Group type: EXPERIMENTAL
Intervention: MyBP
Number of subjects: 62
Study 34239050 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (control)
Number of subjects: 62
Study 32282308 — intervention group
Group type: EXPERIMENTAL
Intervention: Withania somnifera extract, 1g/day, n = 22
Number of subjects: 40
Study 32282308 — intervention group
Group type: COMPARATOR
Intervention: Placebo, n = 18
Number of subjects: 40
Study 32062741 — intervention group
Group type: EXPERIMENTAL
Intervention: ddPCR WT1 assay (0 copies/μl)
Number of subjects: 49
Study 32062741 — intervention group
Group type: EXPERIMENTAL
Intervention: ddPCR WT1 assay (1 to 15.2 copies/μl)
Number of subjects: 49
Study 32062741 — intervention group
Group type: EXPERIMENTAL
Intervention: ddPCR WT1 assay
Number of subjects: 49
Study 32062741 — intervention group
Group type: EXPERIMENTAL
Intervention: ddPCR WT1 results
Number of subjects: 49
Study 35645564 — intervention group
Group type: EXPERIMENTAL
Intervention: Congruence Couple Therapy (CCT)
Number of subjects: 38
Study 35645564 — intervention group
Group type: COMPARATOR
Intervention: Treatment‐as‐Usual (TAU)
Number of subjects: 38
Study 32168168 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV self-testing (HIVST) delivered by women to their male partners
Number of subjects: 1514
Study 32168168 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV self-testing (HIVST)
Number of subjects: 1514
Study 32168168 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control)
Number of subjects: 1514
Study 35982587 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (8 sessions)
Number of subjects: 0
Study 35982587 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study 33950234 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH) treatment for 1 year (n=19)
Number of subjects: 37
Study 33950234 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment for 1 year (n=18)
Number of subjects: 37
Study 32839856 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-printable drilling protection device
Number of subjects: 0
Study 32839856 — intervention group
Group type: COMPARATOR
Intervention: No device
Number of subjects: 0
Study 32576237 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 100
Study 32576237 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 100
Study 35148428 — intervention group
Group type: EXPERIMENTAL
Intervention: Special communication application used by the experimental group.
Number of subjects: 46
Study 35148428 — intervention group
Group type: COMPARATOR
Intervention: Control group (no application used).
Number of subjects: 46
Study 33657562 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergaming 2×/week for 8 weeks
Number of subjects: 160
Study 33657562 — intervention group
Group type: EXPERIMENTAL
Intervention: Exergaming 3×/week for 8 weeks
Number of subjects: 160
Study 33657562 — intervention group
Group type: COMPARATOR
Intervention: Control (0× exergaming)
Number of subjects: 160
Study 35236649 — intervention group
Group type: EXPERIMENTAL
Intervention: Jiawei Qingxuan Jiangya Decoction
Number of subjects: 400
Study 35236649 — intervention group
Group type: COMPARATOR
Intervention: Control group (benazepril hydrochloride tablets)
Number of subjects: 400
Study 33849341 — intervention group
Group type: EXPERIMENTAL
Intervention: Vascular-targeted photodynamic therapy (PDT)
Number of subjects: 0
Study 33849341 — intervention group
Group type: COMPARATOR
Intervention: Active surveillance (AS)
Number of subjects: 0
Study 33849341 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvage radical prostatectomy (sRP) after focal therapy (FT)
Number of subjects: 0
Study 33849341 — intervention group
Group type: COMPARATOR
Intervention: Salvage radical prostatectomy (sRP) after radiation therapy (RT)
Number of subjects: 0
Study 34229502 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression group (Group 1)
Number of subjects: 90
Study 34229502 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical treatment group (Group 2)
Number of subjects: 90
Study 34229502 — intervention group
Group type: EXPERIMENTAL
Intervention: Sclerotherapy group (Group 3)
Number of subjects: 90
Study 34229502 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 90
Study 32673678 — intervention group
Group type: EXPERIMENTAL
Intervention: Various prevention strategies for pelvic organ prolapse (41 strategies identified)
Number of subjects: 1000
Study 32673678 — intervention group
Group type: EXPERIMENTAL
Intervention: Various prevention strategies for urinary tract infection (58 strategies identified)
Number of subjects: 1000
Study 32673678 — intervention group
Group type: EXPERIMENTAL
Intervention: Various prevention strategies for overactive bladder (28 strategies identified)
Number of subjects: 1000
Study 32673678 — intervention group
Group type: EXPERIMENTAL
Intervention: Various prevention strategies for stress urinary incontinence (34 strategies identified)
Number of subjects: 1000
Study 32673678 — intervention group
Group type: EXPERIMENTAL
Intervention: Various prevention strategies for interstitial cystitis (79 strategies identified)
Number of subjects: 1000
Study 34077510 — intervention group
Group type: EXPERIMENTAL
Intervention: Roxadustat
Number of subjects: 616
Study 33084773 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cryotherapy during the infusion of 5-FU
Number of subjects: 60
Study 33084773 — intervention group
Group type: COMPARATOR
Intervention: Physiological serum mouthwash
Number of subjects: 60
Study 33021877 — intervention group
Group type: EXPERIMENTAL
Intervention: Social and Behaviour Change Communication intervention (weekly radio programming, listening and discussion groups, community engagement)
Number of subjects: 1440
Study 33021877 — intervention group
Group type: EXPERIMENTAL
Intervention: Social and Behaviour Change Communication intervention
Number of subjects: 1440
Study 33098800 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive treatment (systolic blood pressure goal of less than 120 mm Hg)
Number of subjects: 2921
Study 33098800 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (systolic blood pressure goal of less than 140 mm Hg)
Number of subjects: 2921
Study 35829925 — intervention group
Group type: COMPARATOR
Intervention: 10 mg tablet
Number of subjects: 80
Study 35829925 — intervention group
Group type: COMPARATOR
Intervention: 50 mg tablet
Number of subjects: 80
Study 35829925 — intervention group
Group type: COMPARATOR
Intervention: 0.72% oral powder formulation
Number of subjects: 80
Study 35829925 — intervention group
Group type: COMPARATOR
Intervention: 7.2% oral powder formulation
Number of subjects: 80
Study 35829925 — intervention group
Group type: COMPARATOR
Intervention: Oral powder formulations with different vehicles (apple juice, apple sauce, yogurt)
Number of subjects: 80
Study 34162353 — intervention group
Group type: EXPERIMENTAL
Intervention: In Balance intervention (14-week, low-cost group fall prevention intervention including educational component and physical exercises based on Tai Chi principles)
Number of subjects: 256
Study 34162353 — intervention group
Group type: COMPARATOR
Intervention: General written physical activity recommendations (control group)
Number of subjects: 256
Study 34162353 — intervention group
Group type: EXPERIMENTAL
Intervention: In Balance intervention
Number of subjects: 256
Study 35537578 — intervention group
Group type: COMPARATOR
Intervention: Conventional RT (78 Gy/39 fractions)
Number of subjects: 96
Study 34638151 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic-dose bemiparin (115 IU/kg daily)
Number of subjects: 70